136 related articles for article (PubMed ID: 19232551)
1. Beta2-glycoprotein I and annexin A5 phospholipid interactions: artificial and cell membranes.
Frank M; Sodin-Semrl S; Irman S; Bozic B; Rozman B
Autoimmun Rev; 2009 Sep; 9(1):5-10. PubMed ID: 19232551
[TBL] [Abstract][Full Text] [Related]
2. Annexin A5 binding to giant phospholipid vesicles is differentially affected by anti-beta2-glycoprotein I and anti-annexin A5 antibodies.
Gaspersic N; Ambrozic A; Bozic B; Majhenc J; Svetina S; Rozman B
Rheumatology (Oxford); 2007 Jan; 46(1):81-6. PubMed ID: 16820381
[TBL] [Abstract][Full Text] [Related]
3. The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis.
Rand JH; Wu XX; Quinn AS; Taatjes DJ
Lupus; 2010 Apr; 19(4):460-9. PubMed ID: 20353989
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism.
de Laat B; Mertens K; de Groot PG
Nat Clin Pract Rheumatol; 2008 Apr; 4(4):192-9. PubMed ID: 18285765
[TBL] [Abstract][Full Text] [Related]
5. The annexin A5 protective shield model revisited: inherited carriage of the M2/ANXA5 haplotype in placenta as a predisposing factor for the development of obstetric antiphospholipid antibodies.
Bogdanova N; Baleva M; Kremensky I; Markoff A
Lupus; 2012 Jun; 21(7):796-8. PubMed ID: 22635237
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic role of anti-beta2-glycoprotein I antibodies on human placenta: functional effects related to implantation and roles of heparin.
Di Simone N; Meroni PL; D'Asta M; Di Nicuolo F; D'Alessio MC; Caruso A
Hum Reprod Update; 2007; 13(2):189-96. PubMed ID: 17099207
[TBL] [Abstract][Full Text] [Related]
7. Interaction of giant phospholipid vesicles containing cardiolipin and cholesterol with beta2-glycoprotein-I and anti-beta2-glycoprotein-I antibodies.
Ambrozic A; Cucnik S; Tomsic N; Urbanija J; Lokar M; Babnik B; Rozman B; Iglic A; Kralj-Iglic V
Autoimmun Rev; 2006 Nov; 6(1):10-5. PubMed ID: 17110310
[TBL] [Abstract][Full Text] [Related]
8. Beta 2-glycoprotein I is a good indicator of certain adverse pregnancy conditions.
Ulcová-Gallová Z; Bouse V; Krizanovská K; Balvín M; Rokyta Z; Netrvalová L
Int J Fertil Womens Med; 2001; 46(6):304-8. PubMed ID: 11795690
[TBL] [Abstract][Full Text] [Related]
9. Phagocytosis of platelet microvesicles and beta2- glycoprotein I.
Abdel-Monem H; Dasgupta SK; Le A; Prakasam A; Thiagarajan P
Thromb Haemost; 2010 Aug; 104(2):335-41. PubMed ID: 20539917
[TBL] [Abstract][Full Text] [Related]
10. Effects of low-molecular-weight heparin on adhesion and vesiculation of phospholipid membranes: a possible mechanism for the treatment of hypercoagulability in antiphospholipid syndrome.
Frank M; Sodin-Semrl S; Rozman B; Potocnik M; Kralj-Iglic V
Ann N Y Acad Sci; 2009 Sep; 1173():874-86. PubMed ID: 19758240
[TBL] [Abstract][Full Text] [Related]
11. Immunochemical properties and pathological relevance of anti-β₂-glycoprotein I antibodies of different avidity.
Žager U; Irman Š; Lunder M; Škarabot M; Muševič I; Hodnik V; Anderluh G; Čučnik S; Kveder T; Rozman B; Božič B
Int Immunol; 2011 Aug; 23(8):511-8. PubMed ID: 21697288
[TBL] [Abstract][Full Text] [Related]
12. A case-control study on the association of idiopathic recurrent pregnancy loss with autoantibodies against beta2-glycoprotein I and annexin V.
Zammiti W; Mtiraoui N; Kallel C; Mercier E; Almawi WY; Mahjoub T
Reproduction; 2006 Apr; 131(4):817-22. PubMed ID: 16595732
[TBL] [Abstract][Full Text] [Related]
13. Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome.
Robbins DL; Leung S; Miller-Blair DJ; Ziboh V
J Rheumatol; 1998 Jan; 25(1):51-6. PubMed ID: 9458202
[TBL] [Abstract][Full Text] [Related]
14. Beta2-glycoprotein I binds thrombin via exosite I and exosite II: anti-beta2-glycoprotein I antibodies potentiate the inhibitory effect of beta2-glycoprotein I on thrombin-mediated factor XIa generation.
Rahgozar S; Yang Q; Giannakopoulos B; Yan X; Miyakis S; Krilis SA
Arthritis Rheum; 2007 Feb; 56(2):605-13. PubMed ID: 17265495
[TBL] [Abstract][Full Text] [Related]
15. Intracellular trafficking of beta2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome.
Kajiwara T; Yasuda T; Matsuura E
J Autoimmun; 2007; 29(2-3):164-73. PubMed ID: 17826950
[TBL] [Abstract][Full Text] [Related]
16. beta2-glycoprotein I, the playmaker of the antiphospholipid syndrome.
Bas de Laat H; Derksen RH; de Groot PG
Clin Immunol; 2004 Aug; 112(2):161-8. PubMed ID: 15240159
[TBL] [Abstract][Full Text] [Related]
17. Characterization of beta2-glycoprotein I binding to phospholipid membranes.
Harper MF; Hayes PM; Lentz BR; Roubey RA
Thromb Haemost; 1998 Oct; 80(4):610-4. PubMed ID: 9798980
[TBL] [Abstract][Full Text] [Related]
18. Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C.
de Laat B; Eckmann CM; van Schagen M; Meijer AB; Mertens K; van Mourik JA
Blood Coagul Fibrinolysis; 2008 Dec; 19(8):757-64. PubMed ID: 19002041
[TBL] [Abstract][Full Text] [Related]
19. Resistance to annexin A5 anticoagulant activity in women with histories for obstetric antiphospholipid syndrome.
Hunt BJ; Wu XX; de Laat B; Arslan AA; Stuart-Smith S; Rand JH
Am J Obstet Gynecol; 2011 Nov; 205(5):485.e17-23. PubMed ID: 21784397
[TBL] [Abstract][Full Text] [Related]
20. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
